Getting Resources There

TB-500

"The logistics coordinator." A lab-made version of one section of a natural protein called Thymosin Beta-4, which your body already produces in many tissues. Studied for how it helps the body move repair cells and materials to where they're needed.

Fragment of Thymosin Beta-4 Acts on actin (cell scaffolding) Studied for cell migration
TB-500 mascot — a courier character

What it is

If a full protein is a large structure made of many small blocks, a peptide is a smaller section of it. TB-500 is a synthetic version of one such section from Thymosin Beta-4, a natural protein present in many of your tissues. Researchers focus on this fragment because it appears to play a role in how the body repairs itself after injury.

A useful way to picture it: a logistics coordinator for healing — getting the right repair materials and cells to the right place at the right time.

How researchers think it works

When tissue is damaged, the body needs to do three things: move repair cells to the injury site, grow new tiny blood vessels for oxygen and nutrients, and rebuild tissue in a flexible, functional way rather than as stiff scar.

Illustrated diagram of TB-500 accelerating cell migration and promoting new blood vessels at an injured cell.
Conceptual overview. TB-500 is studied for making it easier for repair cells to move — a simplified overview, not a clinical claim.

TB-500 supports these steps mainly by influencing actin, a protein that forms part of a cell's internal scaffolding. By helping regulate actin, TB-500 makes it easier for cells to change shape and move — which is why the literature often describes its core job as accelerating cell migration. It's also reported to encourage new blood-vessel growth and to help tissue remodel more cleanly, which can mean less stiff scar tissue and better flexibility in the healed area.

What researchers look at

TB-500 is often discussed alongside BPC-157: the two are studied for different parts of the same repair process — BPC-157 more on structural rebuilding and protection, TB-500 more on getting cells and resources moving efficiently.

What the evidence does not show. The parent molecule, Thymosin Beta-4, does have human Phase 1 safety studies and Phase 2 trials (for dry eye). Importantly, those trials used specific pharmaceutical Thymosin Beta-4 formulations — they should not be read as studies of the "TB-500" sold by research-chemical vendors, which is a shorter fragment and not the same tested product. TB-500 itself is not an approved medicine, it is banned in sport by WADA, and nothing here is a recommendation to use it or a statement of dose.

Keep exploring

Educational and editorial content only. Not medical advice. TB-500 is discussed as a research compound; content may describe emerging research not approved for clinical use.